北米の糖尿病性足潰瘍市場は、2022年に35億7,076万ドルと評価され、2030年までに59億4,356万ドルに達する見込みです。 2022 年から 2030 年までのCAGRは 6.6%と推定されます。
北米の糖尿病性足潰瘍市場は、2022年から2030年にかけてCAGR 6.64%で成長すると推定されます。市場の成長を牽引する主な要因は、糖尿病および関連する慢性創傷の有病率の増加と、高齢者人口の増加です。ただし、高度な創傷治療のコストが高いことが市場の成長を妨げています。この地域の高齢者人口の増加も市場の成長を促進します。 2022年に発行された高齢化局（米国保健福祉省）の報告書によると、2020年の米国の65歳以上の人口は5,570万人でした。高齢者グループは人口の 17%、つまりアメリカ人の 6 人に 1 人に相当します。アーバン研究所（ワシントン DC に本拠を置くシンクタンク）の推計によると、米国では 65 歳以上の人口は今後 40 年間で倍増し、2040 年には 8,000 万人に達します。さらに、2020 年には、糖尿病は 65 歳以上の成人の主要な慢性疾患の 1 つとみなされています。
近年、いくつかの合弁事業、イニシアチブ、およびコラボレーションによって、北米における糖尿病性足潰瘍市場の拡大が加速しました。たとえば、2020年に米国の6つの研究機関が、米国における糖尿病性足潰瘍を研究するために国立衛生研究所の資金提供を受けて史上初の多施設ネットワークを立ち上げました。さらに、糖尿病性足潰瘍の合併症を予防するために、カナダで糖尿病性足潰瘍カナダプログラムが開始されました。したがって、糖尿病の高い有病率と高齢者人口の増加が、この地域の市場の成長を推進します。
目次
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Diabetic Foot Ulcer Market Landscape
4.1 Overview
5. North America Diabetic Foot Ulcer Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:
6. Diabetic Foot Ulcer Market - North America Market Analysis
6.1 North America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030
7. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type
7.1 Overview
7.2 North America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.4 Hydrofiber Dressings
7.3.4.1 Overview
7.3.4.2 Hydrofiber Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.7 Film Dressing
7.3.7.1 Overview
7.3.7.2 Film Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.8 Other Dressings
7.3.8.1 Overview
7.3.8.2 Other Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5.4 Ultrasound Therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type
8.1 Overview
8.2 North America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity
9.1 Overview
9.2 North America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
9.3.1 Overview
9.3.2 Mild: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Moderate: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
9.3.4 Severe: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User
10.1 Overview
10.2 North America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
10.5.1 Overview
10.5.2 Home Care: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
11. Diabetic Foot Ulcer Market - North America Market Analysis
11.1 North America Diabetic Foot Ulcer Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.1.1 North America Diabetic Foot Ulcer Market, by Country
11.1.1.2 US
11.1.1.2.1 US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 US Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.2.3 US Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.2.3.1 US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.2.3.2 US: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.2.3.3 US: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.2.4 US Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.2.5 US Diabetic Foot Ulcer Market, by End User
11.1.1.3 Canada
11.1.1.3.1 Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Canada Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.3.3 Canada Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.3.3.1 Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.3.3.2 Canada: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.3.3.3 Canada: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.3.4 Canada Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.3.5 Canada Diabetic Foot Ulcer Market, by End User
11.1.1.4 Mexico
11.1.1.4.1 Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Mexico Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.4.3 Mexico Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.4.3.1 Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.4.3.2 Mexico: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.4.3.3 Mexico: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.4.4 Mexico Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.4.5 Mexico Diabetic Foot Ulcer Market, by End User
12. North America Diabetic Foot Ulcer Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. North America Diabetic Foot Ulcer Market - Key Company Profiles
13.1 Convatec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast AS
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun SE
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Molnlycke Health Care AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MiMedx Group Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Medline Industries LP
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Organogenesis Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
